Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Roche sues U.S. executives in fight over diabetes test strips

Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker’s latest case targeting what the company calls fraudulent schemes involving its diabetes test strips.

Read More »

Indiana University Researchers Develop Blood Test for PTSD

Researchers at Indiana University developed a blood test that could help more accurately diagnose post-traumatic stress disorder.

Read More »

With new blood test, Roche dives deeper into personal cancer care

Swiss drugmaker Roche upped the company’s bet on personalized cancer treatment and is ready to sell a blood test around the world that can identify common gene mutations from solid tumors from a patient’s blood.

Read More »

EpicGenetics and Massachusetts General Hospital to Launch Fibromyalgia Clinical Trial

EpicGenetics and Massachusetts General Hospital are launching a Phase II clinical trial to test a tuberculosis vaccine, CBG, as a potential treatment for fibromyalgia.

Read More »

Israeli healthcare startup Medial EarlySign raises $30 milliond

Israel’s Medial EarlySign, whose machine-learning based technology is meant to help improve patient management, said on Tuesday it raised $30 million, bringing its total funding to $50 million.

Read More »

Roche blood test could help ‘personalize’ cancer immunotherapy

A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.

Read More »

Quest to offer cholesterol testing without fasting requirement

Quest Diagnostics Inc. will use a more precise method of calculating levels of “bad” LDL cholesterol that no longer requires fasting prior to blood draw, a development likely to delight patients who previously had to refrain from eating for up to 12 hours before testing.

Read More »

Theranos Could Have Lab Again in 2019

Theranos reached a settlement with the Centers for Medicare and Medicaid Services, which could make it eligible to operate a clinical lab within two years.

Read More »

Theranos Failed Again to Inform Patients of Potentially Botched Diabetes Test

Theranos reportedly failed to notify patients in Arizona about potentially deficient diabetes tests.

Read More »

Major Investor Sues Theranos Over ‘Series of Lies’ in $100 Million Suit

A Bay Area hedge fund has filed a lawsuit against embattled Theranos alleging the company duped investors about the efficacy of its products in order to attract investments of nearly $100 million.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom